With the stock's price at Rs 3222.50, Torrent Pharmaceuticals' performance reflects its position in the pharmaceutical sector.

Torrent Pharma, ACME Solar, and DOMS Industries, with 'Buy' calls for strategic growth. Discover investment potential now!

Q4 Results May 20, 2025 updates: Find all the latest Q4 results 2025 updates for Hindalco Industries, Torrent Pharmaceuticals, Gland Pharma, Solar Industries India, Dixon Technologies, Whirlpool of ...

Shares of ONGC, IndiGo, IndusInd Bank, and RVNL are expected to be in the spotlight today as these companies are set to ...

Indian drugmaker Mankind Pharma reported a fourth-quarter profit that beat analysts' estimates on Wednesday, driven by strong ...

Jefferies recommends Buy on DLF, CMS Info Systems, and Torrent Pharma, citing strong fundamentals and growth prospects. Check ...

Ahmedabad: Torrent Pharma has announced the appointment of Aman Mehta, third generation of Torrent Group's founder Mehta ...

Mumbai: Torrent Pharmaceuticals on Wednesday reported a 0.99 per cent quarter-on-quarter (QoQ) decline in its net profit for the fourth quarter (Q4) of FY25, with earnings dropping to Rs 498 crore ...

Torrent Pharmaceuticals added 1.53% to Rs 3,292.95 after the company's consolidated net profit increased 10.91% to Rs 498 crore in Q4 FY25 as against Rs 449 crore posted in Q4 FY24.

Torrent Pharmaceuticals on Wednesday reported a 0.99 per cent quarter-on-quarter (QoQ) decline in its net profit for the ...